 | • レポートコード：QFJ1-4402 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、腎臓癌分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腎臓癌分子診断の市場動向 ・企業の競争状況、市場シェア ・腎臓癌分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・腎臓癌分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・腎臓癌分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・腎臓癌分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓癌分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓癌分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓癌分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biomerieux、Gene+、Annoroad、Geneis、Unitedgene、Inmedi、Sansure、SinoMD、San Valley、Premed） ・結論 |
A molecular approach for diagnosing kidney cancer
Market Analysis and Insights: Global Kidney Cancer Molecular Diagnostics Market
The global Kidney Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kidney Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kidney Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kidney Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kidney Cancer Molecular Diagnostics market.
Global Kidney Cancer Molecular Diagnostics Scope and Market Size
Kidney Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Biomerieux
Gene+
Annoroad
Geneis
Unitedgene
Inmedi
Sansure
SinoMD
San Valley
Premed
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Kidney Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Kidney Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Kidney Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kidney Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Kidney Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Kidney Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Kidney Cancer Molecular Diagnostics Market Trends
2.3.2 Kidney Cancer Molecular Diagnostics Market Drivers
2.3.3 Kidney Cancer Molecular Diagnostics Market Challenges
2.3.4 Kidney Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Kidney Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Kidney Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Molecular Diagnostics Revenue
3.4 Global Kidney Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Kidney Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Molecular Diagnostics Revenue in 2020
3.5 Kidney Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Kidney Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Kidney Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Kidney Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Kidney Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
5 Kidney Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Kidney Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Kidney Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Kidney Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Kidney Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Kidney Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Kidney Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Kidney Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Kidney Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Kidney Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Kidney Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Kidney Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Kidney Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Kidney Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Kidney Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biomerieux
11.1.1 Biomerieux Company Details
11.1.2 Biomerieux Business Overview
11.1.3 Biomerieux Kidney Cancer Molecular Diagnostics Introduction
11.1.4 Biomerieux Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Biomerieux Recent Development
11.2 Gene+
11.2.1 Gene+ Company Details
11.2.2 Gene+ Business Overview
11.2.3 Gene+ Kidney Cancer Molecular Diagnostics Introduction
11.2.4 Gene+ Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Gene+ Recent Development
11.3 Annoroad
11.3.1 Annoroad Company Details
11.3.2 Annoroad Business Overview
11.3.3 Annoroad Kidney Cancer Molecular Diagnostics Introduction
11.3.4 Annoroad Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Annoroad Recent Development
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Kidney Cancer Molecular Diagnostics Introduction
11.4.4 Geneis Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Geneis Recent Development
11.5 Unitedgene
11.5.1 Unitedgene Company Details
11.5.2 Unitedgene Business Overview
11.5.3 Unitedgene Kidney Cancer Molecular Diagnostics Introduction
11.5.4 Unitedgene Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Unitedgene Recent Development
11.6 Inmedi
11.6.1 Inmedi Company Details
11.6.2 Inmedi Business Overview
11.6.3 Inmedi Kidney Cancer Molecular Diagnostics Introduction
11.6.4 Inmedi Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Inmedi Recent Development
11.7 Sansure
11.7.1 Sansure Company Details
11.7.2 Sansure Business Overview
11.7.3 Sansure Kidney Cancer Molecular Diagnostics Introduction
11.7.4 Sansure Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Sansure Recent Development
11.8 SinoMD
11.8.1 SinoMD Company Details
11.8.2 SinoMD Business Overview
11.8.3 SinoMD Kidney Cancer Molecular Diagnostics Introduction
11.8.4 SinoMD Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 SinoMD Recent Development
11.9 San Valley
11.9.1 San Valley Company Details
11.9.2 San Valley Business Overview
11.9.3 San Valley Kidney Cancer Molecular Diagnostics Introduction
11.9.4 San Valley Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 San Valley Recent Development
11.10 Premed
11.10.1 Premed Company Details
11.10.2 Premed Business Overview
11.10.3 Premed Kidney Cancer Molecular Diagnostics Introduction
11.10.4 Premed Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Premed Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Kidney Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Kidney Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Kidney Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Kidney Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Kidney Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Kidney Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Kidney Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Kidney Cancer Molecular Diagnostics Market Trends
Table 13. Kidney Cancer Molecular Diagnostics Market Drivers
Table 14. Kidney Cancer Molecular Diagnostics Market Challenges
Table 15. Kidney Cancer Molecular Diagnostics Market Restraints
Table 16. Global Kidney Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Kidney Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Kidney Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Kidney Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Kidney Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Kidney Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Kidney Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Kidney Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Kidney Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Kidney Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biomerieux Company Details
Table 64. Biomerieux Business Overview
Table 65. Biomerieux Kidney Cancer Molecular Diagnostics Product
Table 66. Biomerieux Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Biomerieux Recent Development
Table 68. Gene+ Company Details
Table 69. Gene+ Business Overview
Table 70. Gene+ Kidney Cancer Molecular Diagnostics Product
Table 71. Gene+ Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Gene+ Recent Development
Table 73. Annoroad Company Details
Table 74. Annoroad Business Overview
Table 75. Annoroad Kidney Cancer Molecular Diagnostics Product
Table 76. Annoroad Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Annoroad Recent Development
Table 78. Geneis Company Details
Table 79. Geneis Business Overview
Table 80. Geneis Kidney Cancer Molecular Diagnostics Product
Table 81. Geneis Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Geneis Recent Development
Table 83. Unitedgene Company Details
Table 84. Unitedgene Business Overview
Table 85. Unitedgene Kidney Cancer Molecular Diagnostics Product
Table 86. Unitedgene Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Unitedgene Recent Development
Table 88. Inmedi Company Details
Table 89. Inmedi Business Overview
Table 90. Inmedi Kidney Cancer Molecular Diagnostics Product
Table 91. Inmedi Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Inmedi Recent Development
Table 93. Sansure Company Details
Table 94. Sansure Business Overview
Table 95. Sansure Kidney Cancer Molecular Diagnostics Product
Table 96. Sansure Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Sansure Recent Development
Table 98. SinoMD Company Details
Table 99. SinoMD Business Overview
Table 100. SinoMD Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. SinoMD Recent Development
Table 102. San Valley Company Details
Table 103. San Valley Business Overview
Table 104. San Valley Kidney Cancer Molecular Diagnostics Product
Table 105. San Valley Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. San Valley Recent Development
Table 107. Premed Company Details
Table 108. Premed Business Overview
Table 109. Premed Kidney Cancer Molecular Diagnostics Product
Table 110. Premed Revenue in Kidney Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Premed Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Kidney Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Kidney Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Kidney Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Kidney Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Kidney Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Kidney Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Kidney Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Kidney Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Kidney Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Kidney Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Kidney Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Kidney Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Kidney Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Kidney Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Kidney Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Kidney Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Kidney Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Kidney Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Kidney Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Kidney Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Kidney Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Kidney Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biomerieux Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Gene+ Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Annoroad Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Geneis Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Unitedgene Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Inmedi Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Sansure Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. SinoMD Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. San Valley Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Premed Revenue Growth Rate in Kidney Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing skin cancer Market Analysis and Insights: Global Skin Cancer Molecular Diagnostics Market The global Skin Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…- 世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
- 世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
- 世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing thyroid cancer Market Analysis and Insights: Global Thyroid Cancer Molecular Diagnostics Market The global Thyroid Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…